Related-Party Transactions

12 Months Ended

Dec. 31, 2025

Related Party Transactions [Abstract]

Related-Party Transactions

Note 11. Related-Party Transactions

Due to Related Parties: Amounts due to related parties consist of cash advances received from the Company’s principal shareholder. Some advances bear no interest and are due on demand while a portion has been converted into a loan to the principal shareholder that provides interest at a rate of 10% per annum. These terms and conditions may not be indicative of what a third-party investor may agree to. As of December 31, 2025 and 2024 amounts due to related-parties totaled $91,085 and $13,536, respectively. As of December 31, 2025, $91,085 is included in non-current liabilities as a $90,000 loan and accrued interest that matures on March 31, 2027. As of December 31, 2024, there is $13,536 included in other current liabilities on the Company’s consolidated balance sheets in connection with advances from the principal shareholder.

The Company’s CEO and principal shareholder is a shareholder of MedScience. In addition, the CEO provides services to MedScience for which he is compensated.

Convertible notes payable, related party: See Note 7.